| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $4.3M | +14.3% |
| SG&A Expense | $6.0M | +5.9% |
| Operating Income | -$10.3M | -9.2% |
| Interest Expense | $5K | — |
| Income Tax | $0 | — |
| Net Income | -$10.1M | -7.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.9M | -43.4% |
| Short-term Investments | $9.2M | -23.4% |
| Current Assets | $18.3M | -25.5% |
| Total Assets | $20.4M | -27.7% |
| Current Liabilities | $998K | -2.8% |
| Total Liabilities | $1.0M | -5.8% |
| Stockholders' Equity | $19.4M | -28.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.0M | — |
| Investing Cash Flow | $3.0M | — |
| Financing Cash Flow | $0 | — |